Jiangsu Hengrui Pharmaceuticals Co., Ltd.
SEC Form 4 insider trading activity
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including BRVE, KLRA, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
Companies traded
Other insiders at BRVE
No insider trading data found for Jiangsu Hengrui Pharmaceuticals Co., Ltd..
Frequently asked questions
How many SEC Form 4 filings has Jiangsu Hengrui Pharmaceuticals Co., Ltd. made?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including BRVE, KLRA since 2026.
Which companies does Jiangsu Hengrui Pharmaceuticals Co., Ltd. trade?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed SEC Form 4 disclosures for 2 companies, including BRVE, KLRA.
When was Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s most recent SEC Form 4 filing?
Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.